Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA kazia therapeutics limited

0.00%

8.0¢

SNO August Brain Mets Conf, page-6

First 6 Last

Share
Profile

Follow
Rich&Poor

1,195 Posts.

937

20/06/20

21:17

Post #: 45347219
Share

Originally posted by needle: ↑

The 2nd ever Annual SNO Brain Metastases Conference, originally planned for Toronto from 13 to 15th August will be virtual this year.
This time coincides exactly with the companies schedule for release of clinical data in breast cancer brain metastases.

The data the company refers to - for sure is the Dana Farber 37 person trial that was mentioned by harvett in these posts 12 months ago.... associated with the 1st Brain Metastases Conference.

See link below, regarding some details of this international conference. NOTE the name of one of the Co-chairs.It so happens, as you would be aware - Priscilla Brastianos is linked with Dana Farber/MGH, where this Kazia BCBM trial has been conducted.

The schedule has not been released. It will be critical when the full schedule is released, to see details and even the possibility that Priscilla will present GDC 0084 conducted at her research hospital/institute. Suggest look for that full schedule release soon, as a significant guide as to success of the Kazia Trial. (Eg if GDC 0084 was not successful, I don't think Kazia would even get a mention at all during the 3 days. - so lets see the full schedule and form some views). This August meeting and as I suggest.....release of results is a very big deal for the company - coming of just that cap of under US$30m.

https://www.soc-neuro-onc.org/SNO/2020BrainMetastases/2020BrainMetastasesHome.aspx

Expand

needle nice find for the virtual SNO Brain Metastases Conference.Dr Jose Leone (Dana Farber) poster if selected for publication may confirm the worth of Paxalisib as a combination therapy with HER2-Positive BCBM.
Agreed, since Dr Priscilla Brastianos is Co-Chair, she may give a presentation on her current research work.

Lots of Paxalisib trials progressing, lots of data accumulating.

Regards.

KZA Price at posting: 46.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

WA8

Warriedar aims for Ricciardo MRE upgrade on 'thick, high-grade' gold and antimony

PTX

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

First 6 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

SNO August Brain Mets Conf, page-6

Top Stories

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Warriedar aims for Ricciardo MRE upgrade on 'thick, high-grade' gold and antimony

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Featured News